Wed, Jul 30, 2014, 5:49 AM EDT - U.S. Markets open in 3 hrs 41 mins


% | $
Click the to save as a favorite.

OncoMed Pharmaceuticals, Inc. Message Board

  • tjsammut4 tjsammut4 Jun 13, 2014 12:16 PM Flag

    Omed is fine and respected


    read the press release carefully - they stopped the trail but fully intend to continue once they fine tune. This is very normal when your testing and they did not cover-up or delay but brought it out in the open, Remember every major player is invested in Omed. Take advantage of this dip and don't forget they have other things in the pipe line -not a one drug wonder. Don't panic, the turtle wins the race. tanks for the under 21 gifts.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • this was a great opportunity to pick up some shares, now long and strong. The sell off, in my humble opinion, was overdone. What happened is something to expect from a P1 trial, and it is good it happened during this trial and not during the P2 or P3. Other positions are NPSP, ITMN, ACRX, TTPH, GILD, PCYC, MGNX, RLYP, LGND. CLDX, ACAD, SGEN, PTX - a little too focussed on Bio/Pharma but this is where real $$ can be made.

      Sentiment: Buy

    • Fully agreed! Some will make more out of this than its worth! OMED, Long and Strong......

      Sentiment: Strong Buy

22.95+0.95(+4.32%)Jul 29 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.